Skip main navigation

Context-sensitive half-time, effect site and Keo

Get to grips with the basic nitty-gritty PK terminology required for a better understanding of the models.

Context-sensitive half-time (CSHT)

  • The time for the plasma concentration (and effect-site concentration) to decrease by 50% after stopping an infusion maintaining a constant plasma concentration
  • The “context” is the duration of that infusion for a drug fitting a multi-compartment model
  • CSHT almost always increases with time (remifentanil is a rare exception as it is metabolised rapidly by cholinesterases in the blood of which there is a ubiquitous supply)
  • Redistribution to the peripheral compartments contributes to the initial drop in the central compartment concentration
  • As peripheral compartments become full (saturated), the cessation of drug effect will depend more on metabolism and elimination from the central compartment. Fentanyl is a good example of this – with short infusions (up to an hour), it wears off quite quickly but this then becomes markedly prolonged.
  • Propofol has an elimination half-life of several hours but wears off quickly after stopping an infusion. This is because central compartments drop with redistribution, rather than metabolism.

Effect-site & keo

  • There is always a delay in effect after achieving a certain drug concentration in the central compartment
  • The effect site is the site of drug action e.g. if this was a beta blocker it would be the heart and the effect would be a decrease in heart rate. With anaesthetics and opioids this will be the CNS and the effect will be consciousness or analgesia
  • A blood-effect equilibrium constant, Keo, is used to describe the delay in clinical effect
  • Often the term “time to peak effect” is used to reflect how long it takes for a drug to act. This, of course, will depend on various factors including Keo
  • The effect compartment has an extremely small volume so it has no influence on the PK model
  • The time lag and the Keo can be estimated from measurement of clinical effects e.g. EEG or auditory evoked potentials for anaesthetics.
  • The Keo affects the speed at which the effect will be obtained
  • The smaller the Keo the longer the time lag between equilibrium being achieved between the plasma and effect-site compartments
  • Keo is critical in effect-site targeting which will be explained later this week. This is crucial and may have led to inaccuracies in effect site targeting with certain models e.g. Schnider
  • The Keo is drug-specific and different Keo may be applied in different models
    • Each drug and the PK models used to describe drug behaviour have their own Keo.
    • Keo may also vary between patients
This article is from the free online

Introduction to Using Total Intravenous Anaesthesia (TIVA)

Created by
FutureLearn - Learning For Life

Reach your personal and professional goals

Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.

Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.

Start Learning now